⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a
very recent recall may be missing. Everything shown is accurate as of the last checked time on this page —
for anything time-critical, confirm with the official sources linked below.
FDAClass II · Drug · Recalled June 24, 2026
Vasopressin 2 Units/2 mL in 0 recall — IntegraDose Compounding Services LLC
Hazard: Subpotent Drug
Class II: may cause temporary or medically reversible health consequences.
View the official FDA enforcement record (openFDA) ↗
- Official recall ID
- D-0593-2026
- Brand
- IntegraDose Compounding Services
- Classification
- Class II
- Units affected
- 287 units
- Recall status
- Ongoing
- Initiated
- Voluntary: Firm initiated
Description
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.
Affected products
Companies & origin
- Recalling firm location
- Shoreview, MN, United States
- Firm address
- 3650 Victoria St N Ste 900, 55126-2906
Identifying details (verbatim from the notice)
- Product codes / lots
- Lot#: 20260327VAS-3, BUD: 05/26/2026; 20260320VAS-3, BUD: 05/19/2026.
- Distribution
- U.S.A. Nationwide
- Firm notified the public via
- Letter
- FDA event ID
- 99014
- Recall initiated
- May 18, 2026
- FDA classified
- June 12, 2026
- FDA report date
- June 24, 2026
Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim;
the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.
Report a data error on this page